Thomas D. Brown's most recent trade in Accelerate Diagnostics Inc was a trade of 69,619 Employee Restricted Stock Units done . Disclosure was reported to the exchange on May 19, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc | Thomas D. Brown | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 69,619 | 0 | - | - | Employee Restricted Stock Units | |
Accelerate Diagnostics Inc | Thomas D. Brown | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 69,619 | 116,160 (0%) | 0% | 0 | Common Stock | |
Accelerate Diagnostics Inc | Thomas D. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 75,949 | 75,949 | - | - | Employee Restricted Stock Units | |
Accelerate Diagnostics Inc | Thomas D. Brown | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 30 Sep 2021 | 8,681 | 46,541 (0%) | 0% | 7.7 | 66,670 | Common Stock |
Accelerate Diagnostics Inc | Thomas D. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 35,168 | 35,168 | - | - | Stock Option (right to buy) | |
Accelerate Diagnostics Inc | Thomas D. Brown | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 09 Apr 2021 | 8,680 | 37,860 (0%) | 0% | 7.7 | 66,662 | Common Stock |
Accelerate Diagnostics Inc | Thomas D. Brown | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 19 Feb 2021 | 8,680 | 29,180 (0%) | 0% | 7.7 | 66,662 | Common Stock |